SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-000428
Filing Date
2022-01-13
Accepted
2022-01-13 08:30:48
Documents
16
Period of Report
2022-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT drma_8k.htm   iXBRL 8-K 29121
2 PRESS RELEASE DATED JANUARY 13, 2022 drma_ex991.htm EX-99.1 7734
3 IMAGE drma_ex991img1.jpg GRAPHIC 5173
  Complete submission text file 0001654954-22-000428.txt   188963

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20220112.xsd EX-101.SCH 5819
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20220112_cal.xml EX-101.CAL 890
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20220112_def.xml EX-101.DEF 3943
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20220112_lab.xml EX-101.LAB 16384
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20220112_pre.xml EX-101.PRE 12145
10 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4803
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 22527956
SIC: 2834 Pharmaceutical Preparations